Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient

Clinical Transplantation
Cheng-Maw HoPo-Huang Lee

Abstract

Sirolimus is one treatment option in transplant recipients with Kaposi's sarcoma (KS), which involves dysregulation of Akt-mammalian target of rapamycin (mTOR) signaling pathway. Signal modifications after sirolimus therapy in organ recipients with KS are largely unknown and not verified. We reported a case of KS found two yr after liver transplantation in which the immunosuppression was changed from tacrolimus, MMF, and steroid to sirolimus alone. In skin, which was found to have persistent KS after a two-month treatment of sirolimus and was removed completely one yr later, KS was no longer present. The patient went well without graft rejection. Tumor biopsies were performed before, two months, and one yr after the start of sirolimus. Immunohistochemical staining of vascular endothelial growth factor (VEGF), p-Akt, p-mTOR, p-p70 S6 kinase, and Western blot for p-tuberin/ tuberous sclerosis complex (TSC)2 was performed. VEGF was suppressed thoroughly in two-month use of sirolimus. In addition, p-Akt and p-mTOR, which were decreased at two months, could not be detected after one yr of treatment. Moreover, p-p70 S6 kinase, expressed strongly in overlying epidermis initially, was suppressed completely after two months of treatment...Continue Reading

References

Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·M S NeshatC L Sawyers
Aug 13, 2002·Nature Cell Biology·Ken InokiKun-Liang Guan
Sep 21, 2002·Molecular and Cellular Biology·Christine C HudsonRobert T Abraham
Feb 1, 2003·Cancer Cell·Gary S Hayward
Feb 4, 2003·Nature Reviews. Molecular Cell Biology·Estela Jacinto, Michael N Hall
Oct 7, 2003·Annual Review of Microbiology·Patrick S Moore, Yuan Chang
Mar 30, 2004·Proceedings of the National Academy of Sciences of the United States of America·Akrit SodhiJ Silvio Gutkind
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
Apr 1, 2005·The New England Journal of Medicine·Giovanni StalloneGiuseppe Grandaliano
Jun 28, 2005·Critical Reviews in Oncology/hematology·Gonzalo Hernández VallejoJuan Carlos de Vicente
Jul 9, 2005·Trends in Molecular Medicine·David A Guertin, David M Sabatini
Jan 13, 2006·British Journal of Cancer·E PetroulakisN Sonenberg
Mar 17, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K ManS T Fan
Apr 11, 2006·The Journal of Clinical Investigation·Marcos G GrisottoSergio A Lira
Jun 22, 2006·International Journal of Clinical Practice·N KolheJ Pattison
Sep 29, 2006·The New England Journal of Medicine·Robert Yarchoan
Dec 13, 2006·International Immunopharmacology·Maria BoratyńskaMarian Klinger
Jan 19, 2007·International Journal of Cancer. Journal International Du Cancer·Sven A LangOliver Stoeltzing
Mar 1, 2007·Transplant International : Official Journal of the European Society for Organ Transplantation·Giuseppe P SegoloniMassimo Gai
Apr 13, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·N BabelP Reinke
Apr 26, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Josep M Campistol, Francesco P Schena
Sep 4, 2007·The Oncologist·Xiaolin Wan, Lee J Helman

❮ Previous
Next ❯

Citations

May 13, 2010·Current Infectious Disease Reports·Meena SunilMary Jo Lechowicz
Feb 9, 2012·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Yu ChenXiao-shun He
Aug 9, 2011·The American Journal of Pathology·Debasmita Roy, Dirk P Dittmer
Feb 24, 2017·Transplantation·Björn Nashan
Oct 15, 2014·Dermatologic Therapy·Blanca Díaz-LeyPedro Jaén-Olasolo
Nov 30, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Alina BadescuAdriana Handra-Luca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.